Illinois Rep Rejoiced Over J&J Baby Powder Discontinuation: 'It Knew for Decades its Product Contains Asbestos'

Medicine & Technology May 20, 2020

On Tuesday, Johnson & Johnson announced that sales of its famous talc-based baby powder would be terminated in the United States and Canada as it faces multiple lawsuits claiming its talc-based baby powder contains asbestos, a cancer-forming substance.

Congo Says No to Johnson & Johnson's Experimental Vaccine

Jul 19, 2019

DRC's health minister has disapproved the use of the pharmaceutical giant, Johnson & Johnson's, new trial vaccine.

Johnson & Johnson's Zytiga Helps Increase Survival Rate For Patient With Severe Prostate Cancer

Jun 05, 2017

American Society of Clinical Oncology (ASCO) presented the research of the effectiveness of Zytiga to boost the survival rate for severe prostate cancers.

Johnson & Johnson Is Asked By FDA To Add Warnings About Leg, Foot Amputations With Diabetes Drug, Invokana

May 17, 2017

The FDA has recently asked the pharmaceutical company, Johnson & Johnson, to add warnings to the diabetes drug Invokana about the risk of leg and the foot amputations.

Johnson & Johnson To Pay $110.5 Million To The Woman Who Said That The Company's Baby Powder Gave Her Cancer

May 11, 2017

A woman blamed Johnson & Johnson's baby powder for causing her ovarian cancer and the jury accepted it.

New Cancer Pill Found More Effective Against Leukemia Than Chemo, Study Shows

Dec 08, 2015

A cancer drug by Johnson & Johnson and AbbVie called Imbruvica can significantly decrease risk of death and slow down disease advancement with an estimated 84 percent lowered risk.

The Investigation into whether Johnson & Johnson Knew about their Harmful Uterine Device

May 29, 2015

Johnson & Johns is under investigation by the FBI for possible prior knowledge about dangers linked to one of their medical devices, the laparoscopic power morcellator, which is supposed to provide a minimally invasive alternative to hysterectomies and removal of fibroid tumors, but in reality, may have been spreading dangerous forms of cancers among its patients.

Pharmacyclics May Soon Be Acquired by Johnson & Johnson for $18 Billion

Mar 03, 2015

Pharmacyclics will ‘possibly’ be acquired by Johnson & Johnson for $18 Billion